Literature DB >> 15104893

Modulation of CpG oligodeoxynucleotide-mediated immune stimulation by locked nucleic acid (LNA).

Jörg Vollmer1, Jan Stenvang Jepsen, Eugen Uhlmann, Christian Schetter, Marion Jurk, Tanja Wader, Meike Wüllner, Arthur M Krieg.   

Abstract

Locked nucleic acid (LNA) is an RNA derivative that when introduced into oligodeoxynucleotides (ODN), mediates high efficacy and stability. CpG ODNs are potent immune stimulators and are recognized by toll-like receptor-9 (TLR9). Some phosphorothioate antisense ODNs bearing CpG dinucleotides have been shown to possess immune modulatory capacities. We investigated the effects of LNA substitutions on immune stimulation mediated by antisense ODN G3139 or CpG ODN 2006. LNA ODNs were tested for their ability to stimulate cytokine secretion from human immune cells or TLR9-dependent signaling. Phosphorothioate chimeric LNA/DNA antisense ODNs with phosphodiester-linked LNA nucleobases at both ends showed a marked decrease of immune modulation with an increasing number of 3' and 5' LNA bases. In addition, guanosine-LNA and cytosine-LNA or simply cytosine-LNA substitutions in the CpG dinucleotides of ODN 2006 led to strong decrease or near complete loss of immune modulation. TLR9-mediated signaling was similarly affected. These data indicate that increasing amounts of LNA residues in the flanks or substitutions of CpG nucleobases with LNA reduce or eliminate the immune stimulatory effects of CpG-containing phosphorothioate ODN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15104893     DOI: 10.1089/154545704322988021

Source DB:  PubMed          Journal:  Oligonucleotides        ISSN: 1545-4576


  14 in total

1.  Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.

Authors:  Jörg Vollmer; Risini D Weeratna; Marion Jurk; Ulrike Samulowitz; Michael J McCluskie; Paul Payette; Heather L Davis; Christian Schetter; Arthur M Krieg
Journal:  Immunology       Date:  2004-10       Impact factor: 7.397

Review 2.  Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through.

Authors:  Eric P Hoffman; Abby Bronson; Arthur A Levin; Shin'ichi Takeda; Toshifumi Yokota; Andreas R Baudy; Edward M Connor
Journal:  Am J Pathol       Date:  2011-05-23       Impact factor: 4.307

3.  Activation of Innate Immune Responses by a CpG Oligonucleotide Sequence Composed Entirely of Threose Nucleic Acid.

Authors:  Margaret J Lange; Donald H Burke; John C Chaput
Journal:  Nucleic Acid Ther       Date:  2018-12-11       Impact factor: 5.486

4.  Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions.

Authors:  Anne-Sophie Beignon; Kelli McKenna; Mojca Skoberne; Olivier Manches; Ida DaSilva; Daniel G Kavanagh; Marie Larsson; Robert J Gorelick; Jeffrey D Lifson; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

5.  Cell-specific RNA interference by peptide-inhibited-peptidase-activated siRNAs.

Authors:  Sandra Koehn; Hendrik W Schaefer; Mirko Ludwig; Natja Haag; Ulrich S Schubert; Lydia Seyfarth; Diana Imhof; Udo R Markert; Tobias G Poehlmann
Journal:  J RNAi Gene Silencing       Date:  2010-12-31

6.  Optimizations of siRNA design for the activation of gene transcription by targeting the TATA-box motif.

Authors:  Miaomiao Fan; Yijun Zhang; Zhuoqiong Huang; Jun Liu; Xuemin Guo; Hui Zhang; Haihua Luo
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

7.  Strategies for In Vivo Screening and Mitigation of Hepatotoxicity Associated with Antisense Drugs.

Authors:  Piotr J Kamola; Klio Maratou; Paul A Wilson; Kay Rush; Tanya Mullaney; Tom McKevitt; Paula Evans; Jim Ridings; Probash Chowdhury; Aude Roulois; Ann Fairchild; Sean McCawley; Karen Cartwright; Nigel J Gooderham; Timothy W Gant; Kitty Moores; Stephen A Hughes; Mark R Edbrooke; Kenneth Clark; Joel D Parry
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-08       Impact factor: 8.886

8.  A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity.

Authors:  Jesper B Bramsen; Maria B Laursen; Anne F Nielsen; Thomas B Hansen; Claus Bus; Niels Langkjaer; B Ravindra Babu; Torben Højland; Mikhail Abramov; Arthur Van Aerschot; Dalibor Odadzic; Romualdas Smicius; Jens Haas; Cordula Andree; Jharna Barman; Malgorzata Wenska; Puneet Srivastava; Chuanzheng Zhou; Dmytro Honcharenko; Simone Hess; Elke Müller; Georgii V Bobkov; Sergey N Mikhailov; Eugenio Fava; Thomas F Meyer; Jyoti Chattopadhyaya; Marino Zerial; Joachim W Engels; Piet Herdewijn; Jesper Wengel; Jørgen Kjems
Journal:  Nucleic Acids Res       Date:  2009-03-12       Impact factor: 16.971

9.  Inhibition of IL-1 Signaling by Antisense Oligonucleotide-mediated Exon Skipping of IL-1 Receptor Accessory Protein (IL-1RAcP).

Authors:  A Seda Yılmaz-Eliş; Annemieke Aartsma-Rus; Peter Ac 't Hoen; Huma Safdar; Cor Breukel; Bart Jm van Vlijmen; Judith van Deutekom; Sjef de Kimpe; Gert-Jan van Ommen; J Sjef Verbeek
Journal:  Mol Ther Nucleic Acids       Date:  2013-01-22       Impact factor: 10.183

10.  Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.

Authors:  Takeshi Kasuya; Shin-Ichiro Hori; Ayahisa Watanabe; Mado Nakajima; Yoshinari Gahara; Masatomo Rokushima; Toru Yanagimoto; Akira Kugimiya
Journal:  Sci Rep       Date:  2016-07-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.